加纳私人保险高血压患者使用抗高血压药物的趋势
Afia Frimpomaa Asare Marfo1, John Serbe Marfo2, Jacob Plange-Rhule3
1Faculty of Pharmacy and Pharmaceutical sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. afamarfo.pharm@knust.edu.gh.
Journal of human hypertension
|January 3, 2024
概括
这项研究分析了加纳的抗高血压药物 (AHM) 模式,发现像CCB这样的常见药物类别经常被使用. 仿制药在单一产品处方中占主导地位,而品牌产品在固定组合中更为常见.
科学领域:
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 高血压管理依赖于抗高血压药物 (AHM).
- 了解AHM的处方模式对于公共卫生倡议和治疗指南的遵守至关重要.
- 加纳特定的AHM利用数据提供了对国家处方趋势的洞察力.
研究的目的:
- 确定加纳国民人口中抗高血压药物 (AHM) 的处方模式.
- 分析AHM类,剂量,人口影响 (性别,年龄) 和通用状态.
- 为了估计药物使用量,按每天1000人群的确定每日剂量 (DDD) 计算.
主要方法:
- 对加纳2016年至2018年私人保险患者索赔数据的分析.
- 检查规定的AHM类,包括通道阻断剂 (CCB), ангиотензинII受体阻断剂 (ARB), ангиотензин转化酶抑制剂 (ACEI),利尿剂和β-阻断剂 (BB).
- 评估单一和固定组合AHM产品的通用和品牌地位.
主要成果:
- 通道阻断剂 (CCB) 是一个主要的类别,安洛迪平是最常用的单一药物.
- 阿姆洛迪平的使用量从2016-2017年的3.92 DDD/1000人/天增加到2018年的4.92.
- 在51-60岁的年龄组中,女性使用CCB几乎是男性使用的两倍 (74.0对38.3 DDD/1000人口/天).
- 在2018年,前十个AHM占所有单一药品的93%.
- 通用产品占单一AHM的大多数 (2018年为83.1%),而品牌产品占固定组合的主导地位 (2018年为91.3%).
结论:
- 在加纳观察到的AHM处方模式与临床预期一致.
- 虽然存在标准治疗指南,但它们对处方线的指导性影响需要进一步评估.
- 这些数据突出了特定的AHM类别的大量使用和CCB利用中的人口统计差异.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
632
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
632
Antihypertensive Drugs: Types of β-Blockers
688
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
688
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
645
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
645
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Antihypertensive Drugs: Vasodilators
528
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
528
Antihypertensive Drugs: Action of β1 Blockers
449
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
449


